Accretion Nutraveda IPO GMP today is Rs 62. Investors can use this GMP along with price band and subscription status for a better IPO review.
Listed
SME IPO
ACCRETIONNUTRAVEDA
Accretion Nutraveda IPO GMP, Subscription & Allotment Status Today
Accretion Nutraveda is a SME IPO with a price band of Rs 122.00 to Rs 129.00 that listed on 04 Feb 2026 at a listing gain of +48.06%. Track its full GMP history, subscription data and listing details here.
- Price Band
- ₹122.00 - ₹129.00
- Lot Size
- 1,000 Shares
- Bidding Closes
- 30 Jan 2026
- Listing Date
- 04 Feb 2026
Current GMP Status
₹62
+48.06% vs upper band
Est. Listing Gain
+48.06%
Last Trend
04 Feb 2026
Listing Price
₹191.00
Retail Entry
₹2,58,000
IPO Details
Complete IPO information
| Current GMP | ₹62 |
|---|---|
| Estimated Listing Gain | +48.06% |
| Price Band | ₹122.00 - ₹129.00 |
| Issue Price | Approx ₹129.00 Crores |
| Listing Price | ₹191.00 |
| Lot Size | 1,000 Shares |
| Issue Type | SME |
| Registrar | TBA |
| Exchange | NSE, BSE |
| Retail Quota | TBA |
| Overall Subscription | TBA |
| Listing Date | 04 Feb 2026 |
| Minimum Investment | ₹2,58,000 |
Analysis
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Accretion Nutraveda is priced at ₹129 per share. With a minimum lot size of 1,000 shares, a retail investor applying for one lot would need approximately ₹2,58,000 to participate in this SME issue.
The latest recorded Grey Market Premium for Accretion Nutraveda stands at ₹62, implying an estimated listing gain of around 48.06% over the issue price if it holds until listing. This is up ₹53 from its previously recorded level. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.
Timeline
IPO roadmap at a glance
✓
Bidding Opens
28 Jan 2026
✓
Bidding Closes
30 Jan 2026
✓
Allotment
TBA
✓
Listing
04 Feb 2026
Grey Market Premium
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 04 Feb 2026 | ₹69.00 | +₹53.00 | 53.49% |
| 03 Feb 2026 | ₹16.00 | +₹10.00 | 12.40% |
| 02 Feb 2026 | ₹6.00 | - | 4.65% |
Swipe to see more →
Market Lot
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lot | 2,000 | ₹2,58,000 |
| Retail Maximum | 2 Lot | 2,000 | ₹2,58,000 |
| S-HNI Minimum | 3 Lot | 3,000 | ₹3,87,000 |
| S-HNI Maximum | 7 Lot | 7,000 | ₹9,03,000 |
| B-HNI Minimum | 8 Lot | 8,000 | ₹10,32,000 |
Swipe to see more →
Fund Utilization
Objects of the Issue & Official Documents
Analysis
Accretion Nutraveda IPO – Key Details
| IPO Open Date | January 27, 2026 |
| IPO Close Date | January 30, 2026 |
| Face Value | ₹10 per Equity Share |
| Price Band | ₹122 – ₹129 per Share |
| Issue Size | Approx ₹24.77 Crores |
| Fresh Issue | Approx ₹24.77 Crores |
| Issue Type | Book Build Issue |
| IPO Listing | BSE SME |
Analysis
Accretion Nutraveda IPO – Market Lot Details
| Application | Lot Size | Shares | Amount (₹) |
|---|---|---|---|
| Retail Minimum | 2 | 2,000 | 2,58,000 |
| Retail Maximum | 2 | 2,000 | 2,58,000 |
| S‑HNI Minimum | 3 | 3,000 | 3,87,000 |
| S‑HNI Maximum | 7 | 7,000 | 9,03,000 |
| B‑HNI Minimum | 8 | 8,000 | 10,32,000 |
Analysis
Accretion Nutraveda IPO – Reservation Details
| Investor Category | Shares Offered | Percentage (%) |
|---|---|---|
| Anchor Investors | – | – |
| QIB (Ex‑Anchor) | 9,08,000 | 47.29% |
| NII | 2,76,000 | 14.37% |
| Retail | 6,40,000 | 33.33% |
Analysis
Accretion Nutraveda IPO – Anchor Investors
| Anchor Bidding Date | January 2026 |
| Anchor Investors List | – |
| Shares Offered to Anchor Investors | – |
| Anchor Size | – |
| Lock‑in Period (50% – 30 Days) | 2026 |
| Lock‑in Period (50% – 90 Days) | 2026 |
Analysis
Accretion Nutraveda IPO – Important Dates
| IPO Open Date | January 27, 2026 |
| IPO Close Date | January 30, 2026 |
| Basis of Allotment | February 2, 2026 |
| Refunds Initiation | February 3, 2026 |
| Credit to Demat Account | February 3, 2026 |
| IPO Listing Date | February 4, 2026 |
| IPO Bidding Cut‑off Time | January 30, 2026 – 5:00 PM |
Analysis
Accretion Nutraveda IPO – Promoters & Holding Pattern
Promoters: Mr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr. Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod & Mr. Vivek Ashok Kumar Patel
| Particulars | Shares | Shareholding (%) |
|---|---|---|
| Promoter Holding (Pre‑Issue) | 53,20,000 | 100.00% |
| Promoter Holding (Post‑Issue) | 72,40,000 | 73.48% |
Analysis
Accretion Nutraveda IPO – Objects of the Issue & Utilisation of Proceeds
| Purpose | Amount (₹ Cr) |
|---|---|
| Purchase of machineries for automation in existing manufacturing unit | 4.22 |
| Purchase of machineries for new manufacturing setup | 8.03 |
| Funding working capital requirements of the company | 5.50 |
| General Corporate Purpose | – |
Analysis
About Accretion Nutraveda IPO
Accretion Nutraveda, since its incorporation in 2021, has been focused on the manufacturing of Ayurvedic and Nutraceutical products in India. It offers Ayurvedic and Nutraceutical products in various dosages and forms, like tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels.
The company serves its customers in India as well as in international countries like Sri Lanka, Singapore, and the USA. The firm blends Ayurvedic and science to offer treatments for various areas, like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness. The company runs a 10,763 sq. ft. manufacturing facility situated in Gujarat. Its unit includes modern infrastructure and quality control systems.
Analysis
Accretion Nutraveda IPO – Company Financial Report
| Period Ended | Revenue (₹ Cr) | Expense (₹ Cr) | PAT (₹ Cr) | Assets (₹ Cr) |
|---|---|---|---|---|
| FY 2023 | 3.07 | 2.78 | 0.28 | 4.06 |
| FY 2024 | 5.20 | 4.28 | 0.82 | 4.64 |
| FY 2025 | 16.06 | 12.87 | 2.61 | 10.86 |
Analysis
Accretion Nutraveda IPO – Valuation (FY2025)
| KPI | Values |
|---|---|
| ROE | 81.22% |
| ROCE | 36.98% |
| EBITDA Margin | 22.79% |
| PAT Margin | 16.33% |
| Debt to Equity Ratio | – |
| Earning Per Share (EPS) | ₹7.19 (Basic) |
| Price / Earnings (P/E) | N/A |
| Return on Net Worth (RoNW) | 48.85% |
| Net Asset Value (NAV) | ₹14.72 |
Analysis
Accretion Nutraveda IPO – Peer Group Comparison
| Company | EPS (₹) | P/E Ratio | RoNW (%) | NAV (₹) | Income (₹ Cr) |
|---|---|---|---|---|---|
| Walpar Nutritions Ltd. | 1.80 | 23.94 | 11.27% | 13.65 | 60.26 |
| Influx Healthtech Limited | 7.31 | 25.93 | 36.72% | 5.31 | 104.99 |
Analysis
IPO Lead Managers aka Merchant Bankers
- Sobhagya Capital Options Pvt. Ltd.
FAQ
Accretion Nutraveda IPO FAQs
Accretion Nutraveda IPO price band is Rs 122.00 to Rs 129.00. Check the latest issue price, lot size and GMP together before applying.
Accretion Nutraveda IPO open date is 28 Jan 2026, close date is 30 Jan 2026, and listing date is 04 Feb 2026.
Accretion Nutraveda IPO lot size is 1,000 shares. The minimum retail investment is Rs 2,58,000.
Accretion Nutraveda is classified as a SME IPO. This helps investors quickly understand the issue category and exchange segment.
Accretion Nutraveda IPO subscription status currently shows Subscription data is currently awaited.
Community discussion
Comments
Share a useful question or insight about Accretion Nutraveda.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Keep Exploring
Similar Recent IPOs
Upcoming
SME
Axiom Gas Engineering
Current GMPN/A
Price Band₹50.00 - ₹53.00
Lot Size2,000 Shares
Upcoming
SME
SpectraA Technology Solutions
Current GMPN/A
Price Band₹112.00 - ₹118.00
Lot Size1,200 Shares
Upcoming
SME
Kheria Autocomp
Current GMPN/A
Price Band₹96.00 - ₹101.00
Lot Size1,200 Shares
Open
SME
Shakti Polytarp
Current GMP₹0
Price Band₹56.00 - ₹59.00
Lot Size2,000 Shares
Loading comments...